Chemical industry trends 2026 point to a familiar set of pressures — slower growth, geopolitical fragmentation, margin compression, and sustainability commitments that still have to justify themselves financially. What has changed is where leaders are looking for advantage. For most of the industry’s history, competitive edge came from what a company could invent: a better molecule, a stronger patent position, a more efficient process. That foundation has not disappeared. But it is no longer where the contest is being decided.
Interviewed separately ahead of CIEX North America 2026 — across different companies, functions, and regions — a group of senior chemical leaders returned repeatedly to the same conclusion: the difficulty is no longer generating innovation. It is scaling it. What follows is a consolidated view of what they told us, organized around the themes the event was built to address.
Chemical Industry Trends 2026: From Pilot to Plant
The constraint most of these leaders described is not a shortage of ideas. It is the difficulty of converting a proven capability into consistent performance across a complex organization. The pattern recurs regardless of function: a promising concept, a successful pilot, and then a stall at the point where the work has to scale.
Lewis Sweet, General Manager Global Refining and Chemicals at Honeywell, states the case plainly. The obstacle, in his view, is rarely the technology itself but the organization’s capacity to embed a working solution consistently across sites and assets. His formulation is deliberately unsparing: the bottleneck is not the tool, it is the enterprise operating around it.
Venki Chandrashekar, President and CEO of AmSty, has observed the same dynamic from within a commoditized business, where there is little tolerance for initiatives that fail to deliver. He describes the recurring failure as the distance between ideation and execution — organizations that generate strong ideas but cannot reproduce them reliably at scale. His remedy is not greater creativity but greater discipline: treating innovation with the same rigor applied to any core business process, complete with defined objectives, measurable outcomes, and clear ownership.
Thanos Yiagopoulos, CTO of Momentive, locates the same problem in the operating environment. Progress comes readily in research settings, where new tools accelerate formulation, scouting, and the screening of technical options. It comes far more slowly on the plant floor, where fragmented data and aging infrastructure resist modernization. The decisive factor, he notes, is often whether the people running those operations trust a new approach enough to change established practice — a question of adoption rather than technical merit.
When advantage is available to everyone
Viewed together, these chemical industry trends 2026 raise a more uncomfortable question. If advantage now depends on operationalizing capability, what remains once competitors operationalize the same capability?
Jayshree Seth, Corporate Scientist and Chief Science Advocate at 3M, confronts the point directly. Optimization, she argues, is not the source of breakthroughs — and when every organization optimizes along the same lines, using the same methods, differentiation erodes. The implication reframes the entire question of adoption. Access to tools confers no lasting edge once that access is universal. What endures is judgment: the discernment to recognize which signal matters, and the discipline to protect the exploratory, non-linear work that cannot be automated.
Michael Lefenfeld, CEO of Hexion, reaches a parallel conclusion from the commercial side of the business. Applying new capability to isolated tasks, he observes, produces incremental gains but no durable position. The more consequential opportunity lies in connecting the enterprise itself — research informed by manufacturing, manufacturing informed by customers — so that the organization compounds its own intelligence over time rather than capturing it in fragments. Advantage, on this account, is a property of the system, not of any single tool within it.
Resilience and discipline, decided in advance
Another defining feature of chemical industry trends 2026 is that execution applies to strategy as much as to operations. Two leaders described resilience and innovation discipline as deliberate commitments, made ahead of need and under real constraint, rather than responses to disruption once it has arrived.
Marc Block, Global VP Performance Chemicals at Wanhua Chemical Group, treats supply chain resilience as a matter of design rather than contingency. A company becomes exposed, he argues, the moment its network is optimized around a single trade-flow assumption or feedstock basis. His account of the trade-off deserves to stand as stated: “the cost of resilience is paid gradually; the cost of fragility arrives all at once when a route closes, a feedstock spikes, or a tariff lands.” Flexibility carries a cost in stable conditions, and accepting that cost is precisely the discipline that separates the prepared from the exposed.
Jamie Cohen, Vice President of R&D, Industrial Intermediates & Infrastructure at Dow, applies the same logic to the innovation pipeline. Under sustained pressure to deliver near-term results, she argues, the conditions for genuine ideation quietly disappear unless an organization protects them by design. Her position is that ideation must be treated as a full business exercise — structured, resourced, and accountable — rather than an activity permitted only when the schedule allows.
Speed as a function of design
A final thread draws the argument together. Even acceleration — the capability most organizations assume can be purchased — proves to be a matter of design rather than expenditure.
These chemical industry trends 2026 point to a broader shift: competitive advantage increasingly depends on how effectively organizations operationalize capability.
Jack Dever, CTO of AVN Corporation, contends that process technology development can move considerably faster than the industry currently accepts as its norm. The gain, however, does not follow from additional resources. It follows from combining sharper work processes with equipment that is well-defined and readily reconfigured, and — he is emphatic on this point — from implementing both together rather than either in isolation. The lesson echoes the others across every function represented here: the binding constraint is not the level of investment, but the deliberateness with which the work itself is designed.
Join the conversation at CIEX North America 2026
These decisions are not being made in isolation — and neither should yours be. In three weeks, the leaders quoted here join CEOs, CTOs, and R&D heads from across the industry for two days of senior, execution-focused exchange on exactly these challenges: scaling AI, building resilience, and turning innovation into measurable performance.
September 9–10, 2026 | Indianapolis
Featuring leaders from 3M, Dow, AVN Corporation, Eastman Chemical, Honeywell, Huntsman, Albemarle, Momentive, Cabot, Hexion, Wanhua Chemical Group, AmSty, and more
Seats are limited as the event approaches.
Taken together, these chemical industry trends 2026 show that execution, resilience, and organizational design are becoming as important as technological innovation itself.
Register for CIEX North America 2026 →
